Clinical trialNCT01637064UnknownObservational

Dermatomyositis and Polymyositis Registry

SponsorPhoenix Neurological Associates, LTDEnrollment100DermatomyositisPolymyositis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

By creating a registry, physicians will have the opportunity to understand the clinical outcomes of Myositis patients treated with Acthar. Despite the availability of clinical exams, muscle biopsies, and other testing, it is surmised that there may be a more important classification of myositis that physicians are not diagnosing which could possibly lead to improper treatment due to inaccurate diagnosis. There may be several types of immune and inflammatory myositis (IIM) that do not fit well into the typical sub classifications of myositis.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Ara Dikranian, MD
Ara Dikranian MD
Principal Investigator
clinicaltrials.gov ↗
Justine Malone, MD
Neurology INC
Principal Investigator
clinicaltrials.gov ↗
Petros Efthimiou, MD
New York Presbyterian Brooklyn Methodist Hospital
Principal Investigator
clinicaltrials.gov ↗
Rup Tandan, MD
University of Vermont
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Todd D Levine, MD
Phoenix Neurological Associates, LTD
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Pna Center for Neurological Research
Phoenix, Arizona, United States
Ara Dikranian Md
San Diego, California, United States
Neurology Inc
Columbia, Missouri, United States
New York Methodist Hospital
Brooklyn, New York, United States
University of Vermont
Burlington, Vermont, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Corticotropin

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2013
Primary completion: 31 Dec 2015
Completion: —
Last update posted: 6 Nov 2015
Registered enrollment: 100
Registry id: NCT01637064

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.